Historique
Bulletin de Périodique
Drug Testing and Analysis , Vol.11, n°7 - July 2019
Paru le :
01/07/2019
Année
2019
Page(s) :
919-1116
Langue(s) :
Anglais
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Note de contenu :
SELECTION :
- A new automated assay for the detection of synthetic urine in drug testing. Silva F., Kaileh I., Hobbs G.A., p. 926-930.
- Decarbonylation: A metabolic pathway of cannabidiol in humans. Kraemer M., Broecker S., Madea B., Hess C., p. 957-967.
- Correlation of creatinine- and specific gravity-normalized free and glucuronidated urine cannabinoid concentrations following smoked, vaporized, and oral cannabis in frequent and occasional cannabis users. Huestis M.A., Blount B.C., Milan D.F., Newmeyer M.N., Schroeder J., Smith M.L., p. 968-975.
- The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogs. Banister S.D., Kevin R.C., Martin L., Adams A., Macdonald C., Manning J.J., et al., p. 976-989.
- The synthetic cathinone psychostimulant alpha-PPP antagonizes serotonin 5-HT2A receptors: In vitro and in vivo evidence. Chen Y., Blough B.E., Murnane K.S., Canal C.E., p. 990-998.
- UHPLC-MS/MS quantitation of porphyroxine in opium and application of porphyroxine-acetylated products as signature markers for heroin. Li L., Panicker S., Casale E.M., p. 999-1008.
- Method validation and preliminary pharmacokinetic studies on the new designer stimulant 3-fluorophenmetrazine (3-FPM). Grumann C., Huppertz L.M., Bisel P., Angerer V., Auwärter V., p. 1009-1017.
- Profiling cocaine residues and pyrolytic products in wastewater by mixed-mode liquid chromatography-tandem mass spectrometry. González-Mariño I., Estévez-Danta A., Rodil R., Da Silva K.M., Sodré F.F., Cela R., et al., p. 1018-1027.
- Pharmacokinetic properties of 4-fluoroamphetamine in serum and oral fluid after oral ingestion. Toennes S.W., Schneider D., Pogoda W., Paulke A., Wunder C., Theunissen E.L., et al., p. 1028-1034.
- A new automated assay for the detection of synthetic urine in drug testing. Silva F., Kaileh I., Hobbs G.A., p. 926-930.
- Decarbonylation: A metabolic pathway of cannabidiol in humans. Kraemer M., Broecker S., Madea B., Hess C., p. 957-967.
- Correlation of creatinine- and specific gravity-normalized free and glucuronidated urine cannabinoid concentrations following smoked, vaporized, and oral cannabis in frequent and occasional cannabis users. Huestis M.A., Blount B.C., Milan D.F., Newmeyer M.N., Schroeder J., Smith M.L., p. 968-975.
- The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogs. Banister S.D., Kevin R.C., Martin L., Adams A., Macdonald C., Manning J.J., et al., p. 976-989.
- The synthetic cathinone psychostimulant alpha-PPP antagonizes serotonin 5-HT2A receptors: In vitro and in vivo evidence. Chen Y., Blough B.E., Murnane K.S., Canal C.E., p. 990-998.
- UHPLC-MS/MS quantitation of porphyroxine in opium and application of porphyroxine-acetylated products as signature markers for heroin. Li L., Panicker S., Casale E.M., p. 999-1008.
- Method validation and preliminary pharmacokinetic studies on the new designer stimulant 3-fluorophenmetrazine (3-FPM). Grumann C., Huppertz L.M., Bisel P., Angerer V., Auwärter V., p. 1009-1017.
- Profiling cocaine residues and pyrolytic products in wastewater by mixed-mode liquid chromatography-tandem mass spectrometry. González-Mariño I., Estévez-Danta A., Rodil R., Da Silva K.M., Sodré F.F., Cela R., et al., p. 1018-1027.
- Pharmacokinetic properties of 4-fluoroamphetamine in serum and oral fluid after oral ingestion. Toennes S.W., Schneider D., Pogoda W., Paulke A., Wunder C., Theunissen E.L., et al., p. 1028-1034.
Cote :
Abonnement